D3 Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$108M
- Investors
-
7
D3 Bio General Information
Description
Developer of biotechnology focused on the development and innovation of drugs in oncology and immunology. The company focuses on the discovery, development, and registration of new medicines in oncology and immunology, aiming to create novel and clinically meaningful new therapies for patients in need.
Contact Information
Website
www.d3bio.comCorporate Office
- Room 324, 88 MeiLiang Road
- Mashan Street, Binhu District
- Wuxi, Jiangsu 214000
- China
Corporate Office
- Room 324, 88 MeiLiang Road
- Mashan Street, Binhu District
- Wuxi, Jiangsu 214000
- China
D3 Bio Timeline
D3 Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series B) | 09-Dec-2025 | $108M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A1) | 08-Apr-2024 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 17-Nov-2020 | $200M | $200M | Completed | Generating Revenue |
D3 Bio Comparisons
Industry
Financing
Details
D3 Bio Competitors (4)
One of D3 Bio’s 4 competitors is Apollomics, a Formerly VC-backed company based in Foster City, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Apollomics | Formerly VC-backed | Foster City, CA | ||||
| CStone Pharmaceuticals | Formerly VC-backed | Suzhou, China | ||||
| BeOne Medicines | Formerly PE-Backed | Beijing, China | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA |
D3 Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
D3 Bio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| IDG Capital | Venture Capital | Minority | ||
| Medicxi Ventures (UK) | Venture Capital | Minority | ||
| Boyu Capital | Asset Manager | Minority | ||
| HSG (Hong Kong) | Venture Capital | Minority | ||
| MPC (Beijing) | Venture Capital | Minority |
D3 Bio FAQs
-
When was D3 Bio founded?
D3 Bio was founded in 2020.
-
Where is D3 Bio headquartered?
D3 Bio is headquartered in Wuxi, China.
-
What industry is D3 Bio in?
D3 Bio’s primary industry is Biotechnology.
-
Is D3 Bio a private or public company?
D3 Bio is a Private company.
-
What is D3 Bio’s current revenue?
The current revenue for D3 Bio is .
-
How much funding has D3 Bio raised over time?
D3 Bio has raised $370M.
-
Who are D3 Bio’s investors?
IDG Capital, Medicxi Ventures (UK), Boyu Capital, HSG (Hong Kong), and MPC (Beijing) are 5 of 7 investors who have invested in D3 Bio.
-
Who are D3 Bio’s competitors?
Apollomics, CStone Pharmaceuticals, BeOne Medicines, and Genetix Biotherapeutics are competitors of D3 Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
